|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03009604 |
|
Date of registration:
|
02/01/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Does Simethicone Improve Operative Field in Gynecological Operations
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
January 2017 |
|
Target sample size:
|
90 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03009604 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Altayeb Mostafa, MBBCh |
|
Address:
|
|
|
Telephone:
|
00201003722811 |
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Altayeb Mostafa |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Gynecological operations for benign conditions as hysterectomy, ovarian cystectomy and
myomectomy.
Exclusion Criteria:
1. History of allergic reaction to study drugs.
2. More than one scar of previous operation.
3. Suspicious of malignancy.
4. Psychiatric disorders.
Age minimum:
20 Years
Age maximum:
60 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Benign Gynecologic Neoplasm
|
|
Intervention(s)
|
|
Drug: Enema
|
|
Drug: Simethicone
|
|
Primary Outcome(s)
|
|
the degree of small & large bowel preparation
[Time Frame: intraoperative]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|